TO could happen anytime. How many TO's wait until P3 results? I don't know.
- Forums
- ASX - By Stock
- NEU
- Ann: Phase 3 trial of trofinetide in Rett syndrome commences
NEU
neuren pharmaceuticals limited
Add to My Watchlist
2.70%
!
$13.67

Ann: Phase 3 trial of trofinetide in Rett syndrome commences, page-21
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$13.67 |
Change
0.360(2.70%) |
Mkt cap ! $1.668B |
Open | High | Low | Value | Volume |
$13.50 | $13.74 | $12.96 | $2.022M | 151.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 193 | $13.66 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.68 | 104 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3 | 13.610 |
3 | 250 | 13.600 |
3 | 482 | 13.590 |
5 | 1676 | 13.580 |
4 | 1225 | 13.570 |
Price($) | Vol. | No. |
---|---|---|
13.640 | 185 | 2 |
13.650 | 459 | 4 |
13.660 | 495 | 3 |
13.670 | 714 | 4 |
13.680 | 1253 | 5 |
Last trade - 11.05am 27/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online